3D Printing
Springer International Publishing (Verlag)
978-3-031-46014-2 (ISBN)
Authored by experts with a broad range of experience, extensive insight into the science of 3D printing technology used to produce these systems is provided. Highlighting viewpoints from the academic, polymer excipient, equipment, product development and regulatory communities, this comprehensive text compiles input from industry thought leaders to illustrate strategies and technologies for applying techniques of additive manufacturing for drug product and device development whilealso providing insight into the path forward for the technology in years to come.
lt;br>
Michael Repka,Dr. Michael A. Repka is Chair and Professor of the Department of Pharmaceutics at The University of Mississippi, as well as Director of the Pii Center for Pharmaceutical Technology. Dr. Repka joined the faculty at Ole Miss after receiving his Ph.D. from The University of Texas College of Pharmacy and founded a pharmaceutical research/development company that specializes in drug delivery. His research interests include oral transmucosal and transdermal/trans-nail delivery systems, as well as other novel dosage forms. Many of these systems are directed toward the solubilization and delivery of poorly soluble bioactives via Hot Melt Extrusion technology, which is a primary focus of his research. Dr. Repka's most important scientific accomplishments involve the advancement of melt extrusion technology. He has established himself as an expert in this major pharmaceutical processing field through his numerous peer-reviewed publications, presentations, and scientific talks.
Nigel Langley, Director Technical Service and Scientific Affairs - BASF Pharma Solutions, provides technical support to the pharmaceutical industry and helps solve drug development challenges with BASF's platform solutions. Prior to joining BASF, Dr. Langley worked for Croda Inc. as Technical Director Health Care, responsible for product and application development for both dietary supplements and Pharmaceutical excipients. He has also worked in Japan and England with Croda. He gained his Chemistry (Hons) degree and PhD (Liquid Crystals) from the University of Hull, (UK) and an MBA from Leeds University (UK). Nigel has been a member of the Executive Committee at IPEC Americas since 2010 and is currently VC membership. He is also helping to lead the Novel excipient initiative in collaboration with the IQ Pharma Consortium. Nigel has 30 years' experience within the Pharmaceutical excipient industry.
Overview of Pharmaceutical 3D Printing Technologies.- Clinical Benefit of 3D Printed Products.- Characterization or Quality Control of 3D Printed Products.- Polymers for HME based 3D Printing.- Cellulosic Polymers.- API and Polymer Selection Formulation and Process Variables.- Fused Deposition Modeling 3D Printing.-Semi-solid Extrusion Printing and 3D.- Future Trends Including Novel Polymeric Excipients Designed for Purpose Bioprinting.
Erscheinungsdatum | 02.12.2023 |
---|---|
Reihe/Serie | AAPS Advances in the Pharmaceutical Sciences Series |
Zusatzinfo | XI, 288 p. 100 illus., 94 illus. in color. |
Verlagsort | Cham |
Sprache | englisch |
Maße | 155 x 235 mm |
Gewicht | 607 g |
Themenwelt | Medizin / Pharmazie ► Pharmazie |
Technik | |
Schlagworte | 3DP • additive pharmaceutical manufacturing • Bioprinting • Drug delivery devices • Fused Deposition Modeling • hot melt extrusion • Personalized medicines • polymeric excipients • polymeric filaments • semi solid extrusion |
ISBN-10 | 3-031-46014-6 / 3031460146 |
ISBN-13 | 978-3-031-46014-2 / 9783031460142 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich